Key Takeaways
- Labour pledges to restore universal free prescriptions from July 2026, funded by a proposed Capital Gains Tax (CGT).
- The policy is estimated to cost NZ $74.5 million per year and will apply only to medicines fully subsidised by Pharmac.
- Hipkins cites survey data showing 155,000 New Zealanders failed to collect prescriptions in 2025 due to cost, linking non‑adherence to higher hospital expenses.
- Health spokesperson Dr Ayesha Verrall references a NZ Medical Journal study estimating $37 million in avoidable hospital costs from missed prescriptions.
- National and ACT criticise the promise as unfunded, reckless spending that favours chain pharmacies and will require an ever‑larger CGT.
- Labour argues the CGT revenue will comfortably cover the prescription policy and allow further health investments, while defending the move as a cost‑saving preventive measure.
Policy Announcement
Labour leader Chris Hipkins unveiled the party’s plan to reinstate universal free prescriptions if it wins the November general election. Speaking at a pharmacy in his Remutaka electorate in Upper Hutt, Hipkins said the measure would begin in July 2026 and cover all medicines fully subsidised by Pharmac. He framed the policy as a simple, patient‑centred solution: “People will be able to see their doctor for free with Labour’s new Medicard, then collect their prescription and pay nothing.” The announcement adds the prescription pledge to Labour’s growing list of health commitments to be financed by a proposed Capital Gains Tax.
Cost and Funding Details
The universal free‑prescription policy is projected to cost the government NZ $74.5 million annually. Health spokesperson Dr Ayesha Verrall broke down the figure, noting that the government had previously funded the removal of prescription charges on repeats at $12 million, reducing the net cost to roughly $62.5 million, with an additional $16 million added to anticipate increased prescribing that might follow fee removal. Only medicines that receive full Pharmac subsidy would be free; partially or non‑subsidised items would retain a $15 co‑payment, which Verrall described as a “small exception” affecting virtually no funded drugs.
Previous Implementation and Criticism
Labour had already introduced free prescriptions in its 2023 Budget, but the subsequent National‑led government repealed the measure, arguing it was too costly and indiscriminate. National’s health spokesperson Ayesha Verrall (then in opposition) criticised the reversal, claiming the savings realised were smaller than anticipated. When National returned to power, it reinstated a $5 annual prescription fee (instead of the previous $5 per three‑month collection) after introducing year‑long prescriptions, a compromise that still left many patients paying out‑of‑pocket.
Health Impact Evidence
Hipkins referenced the 2025 New Zealand Health Survey, which found that approximately 155,000 New Zealanders had been issued prescriptions they did not collect because of cost. He argued that this gap in medication adherence harms individuals and inflates system‑wide expenses. Verrall reinforced the point with a personal anecdote about a truck driver who suffered a stroke after skipping his blood‑pressure medication due to cost, resulting in a costly hospital admission and lasting disability. She also cited a NZ Medical Journal study that estimated $37 million in avoidable hospital costs directly linked to uncollected prescriptions, suggesting broader savings could be realised through improved adherence.
Political Reactions – National
National’s campaign chair Simeon Brown dismissed the Labour pledge as another untargeted spending promise that would strain the anticipated CGT revenue. He maintained that taxpayers’ money should be directed only to those genuinely in need, noting that prescriptions are already free for holders of a Community Services Card, children under 14, seniors over 65, and Prescription Subsidy Card holders. Brown warned that Labour would have to continually expand the CGT to cover its spending, potentially tapping into family homes and retirement savings, and accused the party of being “addicted to spending.”
Political Reactions – ACT
ACT leader David Seymour echoed the criticism, labelling the promise as “another day, another ‘free’ promise from Labour which will end up costing taxpayers.” He characterised the policy as reckless spending that fails to target vulnerable populations and accused Hipkins of cynically buying voter hope without a credible financing plan. Seymour went further, calling Hipkins “the worst kind of politician” who serves personal ambition rather than the public interest.
Labour’s Defence and CGT Revenue
In response, Hipkins insisted that the estimated revenue from the Capital Gains Tax would be sufficient to fund the prescription policy alongside other health initiatives, with possible surplus for future measures. He acknowledged that he had not personally run the calculations but confirmed that the modelling had been completed internally. Hipkins argued that removing cost barriers to medication is a preventive investment that reduces downstream hospital costs, ultimately saving money for the health system and society.
Conclusion and Implications
The debate over universal free prescriptions encapsulates a broader philosophical divide: Labour views the policy as a preventive, equity‑driven measure that improves health outcomes and reduces long‑term expenditure, while National and ACT frame it as an unfunded, blanket subsidy that misallocates scarce resources and encourages fiscal irresponsibility. If Labour secures victory in November, the policy’s implementation from July 2026 could significantly alter medication access patterns, potentially lowering hospital admissions linked to non‑adherence. Conversely, a National‑led government would likely maintain targeted free‑prescription schemes and resist expanding the CGT, preserving the current mixed‑funding model. The outcome will shape not only prescription affordability but also the trajectory of New Zealand’s health‑care financing for the coming years.